sivelestat has been researched along with Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, Y; Kamanaka, Y; Kondo, K; Shimakura, A; Suzuki, Y; Umemura, K | 1 |
1 other study(ies) available for sivelestat and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion.
Topics: Animals; Antilymphocyte Serum; Brain Edema; Brain Ischemia; Cell Count; Cerebral Cortex; Corpus Striatum; Dose-Response Relationship, Drug; Glycine; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Leukocyte Elastase; Male; Neutrophils; Rats; Rats, Wistar; Rose Bengal; Serine Proteinase Inhibitors; Sulfonamides | 2000 |